During the past decade, Cancer Institute of New Jersey at Cooper - Voorhees conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 85 clinical trials were completed, i.e. on average, 4250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 22 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Institute of New Jersey at Cooper - Voorhees" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 44 trials, followed by "Radiation Therapy Oncology Group" with 20 trials sponsored, "Gynecologic Oncology Group" with 12 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored and "NSABP Foundation Inc" with 11 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Institute of New Jersey at Cooper - Voorhees" #1 collaborator was "National Cancer Institute (NCI)" with 110 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Institute of New Jersey at Cooper - Voorhees" are "Breast Cancer" (19 trials), "Leukemia" (15 trials), "Lung Cancer" (15 trials), "Lymphoma" (15 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Cancer Institute of New Jersey at Cooper - Voorhees" in a lesser frequency.

Most popular intervention types in "Cancer Institute of New Jersey at Cooper - Voorhees" are "Drug" (98 trials), "Biological" (33 trials), "Radiation" (33 trials), "Other" (29 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (11 trials), "placebo" (10 trials), "rituximab" (10 trials), "filgrastim" (9 trials) and "methotrexate" (9 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Institute of New Jersey at Cooper - Voorhees" are 93 trials for "All" genders, 34 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Institute of New Jersey at Cooper - Voorhees". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 103 completed trials in Cancer Institute of New Jersey at Cooper - Voorhees, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Institute of New Jersey at Cooper - Voorhees, 1 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

Cancer Institute of New Jersey at Cooper - Voorhees has several departments that took part in Clinical trials: "Delaware Valley Urology, LLC" - 5 trials